Effectiveness and Safety of Traditional Chinese Medicine in Treating COVID-19: Clinical Evidence from China
Author:
Publisher
Aging and Disease
Subject
Cell Biology,Neurology (clinical),Geriatrics and Gerontology,Pathology and Forensic Medicine
Link
http://www.aginganddisease.org/fileup/2152-5250/PDF/1633288858143-190482446.pdf
Reference32 articles.
1. Chen NS, Zhou M, Dong X, Qu JM, Gong FY, Han Y, et al. (2020). Epidemiological and clinical characteristics of 99 cases of 2019 novel corona virus pneumonia in Wuhan, China: a descriptive study. Lancet, 395(10223): 507-513.
2. Zhao FF, Yang ZH, Wang NQ, Jin K, Luo YM (2021). Traditional Chinese Medicine and Western Medicine Share Similar Philosophical Approaches to Fight COVID-19. Aging Dis, 12:1162-1168.
3. Rodriguez-Morales AJ, Cardona-Ospina JA, Gutiérrez-Ocampo E, Villamizar-Peña R, Holguin-Rivera Y, Escalera-Antezana JP, et al. (2020). Latin American Network of Coronavirus Disease 2019-COVID-19 Research (LANCOVID-19): Clinical, Laboratory and Imaging Features of COVID-19: A Systematic Review and Meta-analysis. Travel Med Infect Dis, 34:101623.
4. Xu XW, Wu XX, Jiang XG, Xu KJ, Ying LJ, Ma CL, et al. (2020). Clinical findings in a group of patients infected with the 2019 novel coronavirus (SARS-Cov-2) outside of Wuhan, China: retrospective case series. BMJ, 368:m606.
5. Zhang JJ, Dong X, Cao YY, Yuan YD, Yang YB, Yan YQ, et al. (2020). Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China. Allergy, 75(7):1730-1741.
Cited by 28 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Disease Evolution-based Specificity Target Discovery (DESTD) by analyzing Jiawei-Maxing-Shigan Decoctions against COVID-19;European Journal of Integrative Medicine;2024-09
2. Species classification and origin identification of Lonicerae japonicae flos and Lonicerae flos using hyperspectral imaging with support vector machine;Journal of Food Composition and Analysis;2024-08
3. Chinese Medicine for Treatment of COVID-19: A Review of Potential Pharmacological Components and Mechanisms;Chinese Journal of Integrative Medicine;2024-07-03
4. Danshen-Shanzha formula for the treatment of atherosclerosis: ethnopharmacological relevance, preparation methods, chemical constituents, pharmacokinetic properties, and pharmacological effects;Frontiers in Pharmacology;2024-06-07
5. Methyl rosmarinate is an allosteric inhibitor of SARS-CoV-2 3 CL protease as a potential candidate against SARS-cov-2 infection;Antiviral Research;2024-04
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3